Financial News
Nano Hearing Aids' CEO Targets Key Global Markets With Ambitious Worldwide Tour
Nano Hearing Aids, (888-310-NANO), a leading provider of FDA-registered, over-the-counter (OTC) hearing devices, announces its CEO, Ryan F. Zackon, will begin a four-week global tour aimed at strengthening strategic partnerships and further expanding the company’s international presence.
Coppell, United States - October 15, 2024 —
With visits to key markets that include Toronto, Singapore, Dubai, Paris, and Berlin, Zackon is scheduled to meet with employees, partners, and distributors to discuss the company’s new FDA-registered products ready for launch, and to share insights on the latest advancements in OTC hearing aid technology.
More information is available at https://nanohearingaids.com/blogs/in-the-news/nano-ceo-kicks-off-global-tour-to-deepen-partnerships-and-expand-international-presence
Nearly 30 million adults in the U.S. experience some degree of hearing loss, yet just under 20 percent of those who could benefit from a hearing aid seek treatment. To provide more affordable, easily accessible hearing solutions, the FDA established a new category of over-the-counter (OTC) hearing aids for adults with mild to moderate hearing loss, effective October 2022. This initiative eliminated the need for medical visits, hearing tests, and high-price prescription hearing devices.
A leader in the OTC segment for nearly a decade, Nano Hearing Aids is known for its technologically advanced, needs-based hearing aid solutions. Winner of the Top ENT Solution Provider award in 2023, the company is committed to providing cutting-edge products, 24/7 customer care, and superior value.
Throughout his tour - which also includes public events and press conferences - Zackon’s focus will be on reinforcing Nano’s commitment to expanding its international footprint, fostering meaningful business relationships in key markets, and driving growth within the hearing aid industry.
“This tour marks a pivotal moment for Nano Hearing Aids as we focus on the future and work toward expanding our global presence,” says Zackon. “By meeting with stakeholders directly, we can gain a deeper understanding of regional challenges and opportunities, enabling us to drive innovation and offer tailored hearing solutions that meet the needs of diverse populations worldwide.”
Exemplifying Nano’s advancements in OTC hearing aid technology are its newest products, the completely-in-canal (CIC) First Ear Plus and First Ear Pro OTC hearing aids. The company’s smallest hearing aids yet, these devices are available in 2 and 4-program formats, feature easy push button controls and offer more power than previous models. With prices starting at just under US$300, Nano Hearing Aids makes critical hearing aid solutions accessible to more adults with perceived mild to moderate hearing loss.
Driven by a commitment to innovation, quality, and customer satisfaction, Nano Hearing Aids has experienced significant growth over the past year. Zackon's tour highlights the company's commitment to strengthening global partnerships and to steadily expanding its presence in emerging markets.
Learn more at https://nanohearingaids.com
Contact Info:
Name: Media Inquiries
Email: Send Email
Organization: Hearing At Home LLC
Address: 511 South Royal Lane, Coppell, TX 75019, United States
Phone: +1-404-822-3309
Website: https://hearingathome.com/
Source: PressCable
Release ID: 89143778
Should any errors, concerns, or inconsistencies arise from the content provided in this press release that require attention or if a press release needs to be taken down, we kindly request that you immediately contact us at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will be at your disposal for timely assistance within 8 hours – taking necessary measures to rectify identified issues or providing guidance on the removal process. We prioritize delivering accurate and reliable information.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.